Cancer genetics
Can breast cancer risk come from my father’s side?
When a clinician asks about breast cancer in the family, a father’s sister belongs in the conversation just as much as a mother’s sister.

Why both branches of your family count
Yes—inherited breast cancer susceptibility can come from your father’s side. Everyone has BRCA1 and BRCA2 genes and inherits a copy of each from each parent. A gene is a segment of DNA containing instructions for a biological function. These genes help make proteins involved in repairing damaged DNA. Their inheritance does not depend on whether the parent passing them on has had cancer. That makes a father’s sister relevant to a breast cancer family history, just as a mother’s sister is. Looking at both branches gives a clinician a more complete picture. It does not establish that an inherited harmful change is present; it helps identify which family details deserve closer discussion.
From DNA instructions to repair
DNA repair is the central biological connection between these genes and cancer susceptibility. BRCA1 and BRCA2 proteins support repair processes that help cells maintain their genetic information. A harmful change that reduces a protein’s function can compromise that protective work. This helps explain why certain inherited changes can increase the chance of breast, ovarian and some other cancers, without making cancer inevitable. A variant means a difference in a DNA sequence. The supplied term pathogenic loss-of-function variants describes disease-related changes that impair normal gene function; it is a category, not one specific DNA spelling change. Not every BRCA variant is harmful. The important question is therefore not simply whether a report mentions a variant, but how that particular finding is classified.
What the one-in-two chance actually means
When a parent carries a harmful variant in one of their two copies of a BRCA gene, each child has a 50 percent chance of inheriting that variant. This applies whether the carrier is the father or the mother. It also applies whether that parent has developed cancer or remains unaffected. Each child’s inheritance is considered separately. Crucially, 50 percent describes the chance of receiving the variant, not the chance of developing cancer. Genotype means a person’s genetic makeup, including a particular variant they carry. Phenotype means observable characteristics, including whether cancer develops and the age at diagnosis. A genotype can influence a phenotype without determining it completely. An unaffected parent’s health history therefore cannot, by itself, rule out a harmful inherited variant.
A family pattern is a clue, not a verdict
One relative with breast cancer does not automatically mean a family carries a harmful BRCA change. The cancer type, age at diagnosis and pattern across relatives all matter. Recording those details on the correct family branch is more informative than writing only “cancer runs in the family.” Unknown details can stay marked as unknown rather than becoming guesses. This is also where association and causation need separating. A pattern of cancer in a family can suggest inherited susceptibility, but the pattern alone does not prove that a particular gene caused those cancers. For harmful BRCA variants, evidence includes their role in DNA repair and their relationship with increased cancer risk. Even then, a family story cannot identify an individual’s genotype or predict their future with certainty.
Why the starting point for testing matters
If testing is appropriate, beginning with a relative who has had cancer often gives the family a clearer answer. Finding a harmful inherited variant in that relative can establish a specific finding that other relatives can discuss with a genetics professional. This is more informative than assuming that every family with breast cancer shares the same genetic explanation. A negative result needs context. If a known family variant is absent, the interpretation differs from a negative test in a family where no harmful variant has been identified. Appropriate test coverage matters too: what a test examines affects the questions it can answer. Counseling brings the family history, the person’s phenotype and the test’s scope together. Testing is not automatically necessary for everyone.
Reading uncertainty without turning it into alarm
Some findings are classified as variants of uncertain significance, often shortened to VUS. This means there is not enough evidence to decide whether the change increases cancer risk. A VUS is not treated as a pathogenic variant. The word “variant” on its own is therefore not a diagnosis, and uncertainty should not be translated into a definite inherited cancer risk. Likewise, a harmful variant indicates susceptibility, not a promise that cancer will occur. Genetic results and family history answer related but different questions: one concerns DNA findings, while the other describes what has happened to relatives. A genetics professional can explain the evidence limits and what a result does or does not establish. The goal is informed understanding, not a frightening label.
Sources & further reading
- National Cancer Institute · BRCA changes and testing ↗
- National Cancer Institute · BRCA1 and BRCA2: cancer risks and genetic assessment ↗
Educational reading to enrich your conversation with a healthcare professional, interpreted in the context of your own health and needs.
